Markup of H.R. 1222, H.R. 2410, and H.R. ____, FDA Reauthorization Act of 2017, Subcommittee on Health (May 18, 2017)
The Subcommittee on Health met in open markup session on Thursday, May 18, 2017, at 10:00 a.m., in 2123 Rayburn House Office Building.
Livestream
Key Documents
Memorandum from Ranking Member Pallone to the Subcommittee on Health
Opening Statement of Ranking Member Pallone as prepared for delivery
Legislation
H.R. 1222, Congenital Heart Futures Reauthorization Act of 2017 was adopted, as amended, by a voice vote
Amendment in the Nature of a Substitute offered by Rep. Bilirakis was adopted by a voice vote
H.R. 2410, Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017was adopted by a voice vote
H.R. 2430 FDA Reauthorization Act of 2017 was adopted, as amended, by a voice vote
Amendment offered by Reps. Kennedy and Blackburn was adopted by a voice vote
Amendment offered by Reps. Butterfield, Bucshon, and Brookswas adopted by a voice vote
Amendment offered by Reps. Green, Burgess, and Lancewas adopted by a voice vote
Amendment offered by Reps. Schrader and Bilirakis was adopted by a voice vote